AxioMed Files 1st PMA Module with Freedom Lumbar Disc

AxioMed seeks to secure FDA clearance in 2022 to press its leadership position as the only viscoelastic total disc replacement to complete a lumbar IDE clinical study in the USA. This submission of over 3,700 pages of Module I documents was submitted to FDA at the end of October 2021.

Competitive ball and socket designs on the market have been...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us